XML 17 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2020
Revenue:      
Revenue $ 388,225 $ 308,632 $ 279,271
Cost of sales:      
Amortization 5,297 4,498 4,487
Total cost of sales 171,939 141,975 135,299
Gross profit 216,286 166,657 143,972
Operating expenses:      
Sales and marketing 70,366 61,909 52,761
Research and development 55,098 46,623 43,765
General and administrative 58,527 40,830 36,140
Restructuring Charges 275 995 117
Total operating expenses 178,066 156,129 132,655
Operating income 38,220 10,528 11,317
Other expense, net:      
Interest income 11 10 304
Interest expense (19,701) (1,395) (3,592)
Other income (expense), net 98 (144) (566)
Total other expense, net (19,592) (1,529) (3,854)
Income before income taxes 18,628 8,999 7,463
Income tax benefit (755) (1,367) (948)
Net income $ 19,383 $ 10,366 $ 8,411
Net income per common share:      
Basic $ 0.55 $ 0.32 $ 0.29
Diluted net income per common share:      
Diluted $ 0.54 $ 0.31 $ 0.28
Weighted average common shares:      
Basic (shares) 35,031,000 32,111,000 28,849,000
Diluted (shares) 35,995,000 33,394,000 29,546,000
Change in fair value of contingent consideration $ (6,200) $ 5,772 $ (128)
Product      
Revenue:      
Revenue 290,170 265,805 248,374
Cost of sales:      
Cost of sales 140,615 124,065 118,322
Service      
Revenue:      
Revenue 98,055 42,827 30,897
Cost of sales:      
Cost of sales $ 26,027 $ 13,412 $ 12,490